RLAYRelay Therapeutics, Inc.

Nasdaq relaytx.com


$ 6.63 $ 0.17 (2.63 %)    

Monday, 29-Apr-2024 11:29:50 EDT
QQQ $ 431.53 $ -1.62 (-0.37 %)
DIA $ 383.00 $ -0.19 (-0.05 %)
SPY $ 509.27 $ -0.99 (-0.19 %)
TLT $ 88.84 $ 0.18 (0.2 %)
GLD $ 216.34 $ 0.13 (0.06 %)
$ 6.37
$ 6.46
$ 6.62 x 200
$ 0.00 x 0
$ 6.36 - $ 6.71
$ 5.70 - $ 13.32
769,751
na
780.81M
$ 1.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-27-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 relay-therapeutics-q4-2023-gaap-eps-067-beats-075-estimate

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 relay-therapeutics--files-prospectus-of-proposed-resale-or-other-disposition-by-selling-stockholder-of-offering-of-25m-shares-of-common-stock

-SEC Filing

 hc-wainwright--co-maintains-buy-on-relay-therapeutics-lowers-price-target-to-17

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

 hc-wainwright--co-maintains-buy-on-relay-therapeutics-lowers-price-target-to-19

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

 relay-therapeutics-q3-eps-054-beats-083-estimate-sales-2520m-up-from-34400k-yoy

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(...

 earnings-scheduled-for-november-2-2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

 hc-wainwright--co-maintains-buy-on-relay-therapeutics-raises-price-target-to-33

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price targ...

 relay-therapeutics-reports-initial-clinical-data-for-rly-4008-lirafugratinib-in-patients-with-fgfr2-altered-solid-tumors-says-pipeline-updates-extend-cash-runway-by-1-year-into-2h2026

The data demonstrate activity across several sub-groups, including patients with FGFR2-fusion tumors and patients with FGFR2-al...

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 386 stocks made new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION